Vivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90 based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. The firm's product, RadioGel, is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company was founded by James C. Katzaroff on December 23, 1994 and is headquartered in Richland, WA.
No Data
No Data
No Data